dextrothyroxine has been researched along with Communicable Diseases, Emerging in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aumaître, H; Bertrand, K; Cornaglia, J; Jean, M; Nickel, B; Roy, M | 1 |
| Bailey, RL; Chiodini, PL; Godfrey-Faussett, P; Herman, JS; van-Tulleken, C; Wall, EC | 1 |
| Cerdá, JC; de las Marinas, MD; Felix, R; García, A; Martorell, A; Navalpotro, D | 1 |
3 other study(ies) available for dextrothyroxine and Communicable Diseases, Emerging
| Article | Year |
|---|---|
Gnathostomiasis in Brazil: an emerging disease with a challenging diagnosis.
Topics: Aged; Albendazole; Animals; Anthelmintics; Brazil; Communicable Diseases, Emerging; Gnathostoma; Gnathostomiasis; Humans; Ivermectin; Male | 2016 |
Gnathostomiasis acquired by British tourists in Botswana.
Topics: Adult; Albendazole; Animals; Antinematodal Agents; Botswana; Communicable Diseases, Emerging; Gnathostoma; Humans; Ivermectin; Larva Migrans; Male; Risk Factors; Spirurida Infections; Travel; United Kingdom | 2009 |
Strongyloidiasis: an emerging infectious disease that simulates allergic diseases.
Topics: Adult; Animals; Anti-Allergic Agents; Communicable Diseases, Emerging; Cough; Diagnosis, Differential; Environmental Exposure; Feces; Humans; Hypersensitivity; Immunoglobulin E; Ivermectin; Male; Strongyloides; Strongyloidiasis; Treatment Failure; Wetlands | 2012 |